Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction

BACKGROUND: Heart failure with ejection fraction (HFpEF) is a syndrome resulting from several co-morbidities in which specific mediators are unknown. The platelet proteome responds to disease processes. We hypothesize that the platelet proteome will change composition in patients with HFpEF and may...

Descripción completa

Detalles Bibliográficos
Autores principales: Raphael, Roseanne, Purushotham, Diana, Gastonguay, Courtney, Chesnik, Marla A., Kwok, Wai-Meng, Wu, Hsiang-En, Shah, Sanjiv J., Mirza, Shama P., Strande, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719542/
https://www.ncbi.nlm.nih.gov/pubmed/26792056
http://dx.doi.org/10.1186/s12967-016-0774-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719542/
https://www.ncbi.nlm.nih.gov/pubmed/26792056
http://dx.doi.org/10.1186/s12967-016-0774-3

Ejemplares similares